» Articles » PMID: 17329324

Epitope-dependent Avidity Thresholds for Cytotoxic T-lymphocyte Clearance of Virus-infected Cells

Overview
Journal J Virol
Date 2007 Mar 3
PMID 17329324
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Cytotoxic T lymphocytes (CTLs) are crucial for immune control of viral infections. "Functional avidity," defined by the sensitizing dose of exogenously added epitope yielding half-maximal CTL triggering against uninfected target cells (SD(50)), has been utilized extensively as a measure of antiviral efficiency. However, CTLs recognize infected cells via endogenously produced epitopes, and the relationship of SD(50) to antiviral activity has never been directly revealed. We elucidate this relationship by comparing CTL killing of cells infected with panels of epitope-variant viruses to the corresponding SD(50) for the variant epitopes. This reveals a steeply sigmoid relationship between avidity and infected cell killing, with avidity thresholds (defined as the SD(50) required for CTL to achieve 50% efficiency of infected cell killing [KE(50)]), below which infected cell killing rapidly drops to none and above which killing efficiency rapidly plateaus. Three CTL clones recognizing the same viral epitope show the same KE(50) despite differential recognition of individual epitope variants, while CTLs recognizing another epitope show a 10-fold-higher KE(50), demonstrating epitope dependence of KE(50). Finally, the ability of CTLs to suppress viral replication depends on the same threshold KE(50). Thus, defining KE(50) values is required to interpret the significance of functional avidity measurements and predict CTL efficacy against virus-infected cells in pathogenesis and vaccine studies.

Citing Articles

Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa.

Beavis A, Wee E, Akis Yildirim B, Borthwick N, He B, Hanke T Front Immunol. 2023; 14:1186478.

PMID: 37529048 PMC: 10390215. DOI: 10.3389/fimmu.2023.1186478.


Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation.

Wagner-Drouet E, Teschner D, Wolschke C, Schafer-Eckart K, Gartner J, Mielke S Diagnostics (Basel). 2021; 11(2).

PMID: 33671952 PMC: 7919014. DOI: 10.3390/diagnostics11020312.


Chimeric Antigen Receptors Targeting Human Cytomegalovirus.

Ali A, Chiuppesi F, Nguyen M, Hausner M, Nguyen J, Kha M J Infect Dis. 2020; 222(5):853-862.

PMID: 32285133 PMC: 7399702. DOI: 10.1093/infdis/jiaa171.


Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.

Grossman M, Hofmann C, Ng H, Yang O AIDS. 2019; 33(10):1565-1574.

PMID: 31306165 PMC: 7046083. DOI: 10.1097/QAD.0000000000002259.


Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.

Ruiz A, Blanch-Lombarte O, Jimenez-Moyano E, Ouchi D, Mothe B, Pena R Front Immunol. 2019; 9:3162.

PMID: 30723480 PMC: 6349966. DOI: 10.3389/fimmu.2018.03162.


References
1.
Nelson D, Bundell C, Robinson B . In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. J Immunol. 2000; 165(11):6123-32. DOI: 10.4049/jimmunol.165.11.6123. View

2.
Betts M, Krowka J, Santamaria C, Balsamo K, Gao F, Mulundu G . Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J Virol. 1997; 71(11):8908-11. PMC: 192363. DOI: 10.1128/JVI.71.11.8908-8911.1997. View

3.
Fukada K, Tomiyama H, Wasi C, Matsuda T, Kusagawa S, Sato H . Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients. AIDS. 2002; 16(5):701-11. DOI: 10.1097/00002030-200203290-00005. View

4.
OConnor D, Allen T, Vogel T, Jing P, DeSouza I, Dodds E . Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med. 2002; 8(5):493-9. DOI: 10.1038/nm0502-493. View

5.
Cohen W, Bianco A, Connan F, Camoin L, Dalod M, Lauvau G . Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1. J Virol. 2002; 76(20):10219-25. PMC: 136577. DOI: 10.1128/jvi.76.20.10219-10225.2002. View